The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Kim, Hae Rim ^a   Kim, Kyoung Woon ^b,c   Kim, Bo Mi ^b,c   Cho, Mi La ^b,c   Lee, Sang Heon ^a  

^a Konkuk University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A;

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; MONOCYTE; OSTEOCLAST; OSTEOCLASTOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTRACELLULAR SPACE; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION;

ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; MALE; MIDDLE AGED; MONOCYTES; OSTEOCLASTS; RANK LIGAND; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84928809352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124909     Document Type: Article

References (50)

1. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990; 322: 1277-1289. PMID: 2271017
2. Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood. 2003; 101: 560-567. PMID: 12393422
3. Konisti S, Kiriakidis S, Paleolog EM. Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol. 2012; 8: 153-162. doi: 10.1038/nrrheum.2011.205 PMID: 22293762
4. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13: 9-22. PMID: 9872925
5. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. The Journal of biological chemistry. 1995; 270: 31189-31195. PMID: 8537383
6. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. The Journal of biological chemistry. 1994; 269: 6271-6274. PMID: 8119973
7. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 1995; 55: 4140-4145. PMID: 7545086
8. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM, et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest. 1996; 98: 482-489. PMID: 8755660
9. Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001; 19: 321-324. PMID: 11407088
10. Koch AE. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998; 41: 951-962. PMID: 9627005
11. Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, et al. Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol. 1998; 27: 377-380. PMID: 9808403
12. Kikuchi K, Kubo M, Kadono T, Yazawa N, Ihn H, Tamaki K. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol. 1998; 139: 1049-1051. PMID: 9990370
13. Yoo SA, Kwok SK, Kim WU. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm.2008; 2008: 129873. doi: 10.1155/2008/129873 PMID: 19223981
14. Yoo SA, Bae DG, Ryoo JW, Kim HR, Park GS, Cho CS, et al. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes. J Immunol. 2005; 174: 5846-5855. PMID: 15843589
15. Szekanecz Z, Koch AE. Endothelial cells in inflammation and angiogenesis. Curr Drug Targets Inflamm Allergy. 2005; 4: 319-323. PMID: 16101540
16. Ryu S, Lee JH, Kim SI. IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin Rheumatol. 2006; 25: 16-20. PMID: 16163444
17. Cho ML, Jung YO, Moon YM, Min SY, Yoon CH, Lee SH, et al. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett. 2006; 103: 159-166. PMID: 16368150
18. Kim HR, Park MK, Cho ML, Yoon CH, Lee SH, Park SH, et al. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol. 2007; 34: 927-936. PMID: 17407222
19. Kim WU, Kang SS, Yoo SA, Hong KH, Bae DG, Lee MS, et al. Interaction of vascular endothelial growth factor 165 with neuropilin-1 protects rheumatoid synoviocytes from apoptotic death by regulating Bcl-2 expression and Bax translocation. J Immunol. 2006; 177: 5727-5735. PMID: 17015762
20. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Annals of the rheumatic diseases. 1996; 55: 816-822. PMID: 8976638
21. Kasama T, Kobayashi K, Yajima N, Shiozawa F, Yoda Y, Takeuchi HT, et al. Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA). Clin Exp Immunol.2000; 121: 533-538. PMID: 10971521
22. Mould AW, Tonks ID, Cahill MM, Pettit AR, Thomas R, Hayward NK, et al. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis and rheumatism. 2003; 48: 2660-2669. PMID: 13130487
23. Choi ST, Kim JH, Seok JY, Park YB, Lee SK. Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model. Clin Rheumatol. 2009; 28: 333-337. doi: 10.1007/s10067-008-1075-x PMID: 19101756
24. De Bandt M, Ben Mahdi MH, Ollivier V, Grossin M, Dupuis M, Gaudry M, et al. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/ BxN model of rheumatoid arthritis. J Immunol. 2003; 171: 4853-4859. PMID: 14568965
25. Aldridge SE, Lennard TW, Williams JR, Birch MA. Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone. Br J Cancer. 2005; 92: 1531-1537. PMID: 15812559
26. Yang Q, McHugh KP, Patntirapong S, Gu X, Wunderlich L and Hauschka PV. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol. 2008; 27: 589-599. doi: 10.1016/j.matbio.2008.06.005 PMID: 18640270
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and rheumatism. 1988; 31: 315-324. PMID: 3358796
28. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis and rheumatism. 1986; 29: 1039-1049. PMID: 3741515
29. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Annals of the rheumatic diseases. 1957; 16: 494-502. PMID: 13498604
30. Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis and rheumatism. 2007; 56: 1076-1086. PMID: 17393416
31. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis and rheumatism. 2005; 52: 2656-2665. PMID: 16142732
32. Wu Y, Liu J, Feng X, Yang P, Xu X, Hsu HC, et al. Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis. Arthritis and rheumatism. 2005; 52: 3257-3268. PMID: 16200600
33. Kim KW, Kim HR, Park JY, Park JS, Oh HJ, Woo YJ, et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis and rheumatism. 2012; 64: 1015-1023. doi: 10.1002/art.33446 PMID: 22034096
34. Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical science. 2005; 109: 227-241. PMID: 16104843
35. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397: 315-323. PMID: 9950424
36. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America. 1998; 95: 3597-3602. PMID: 9520411
37. Fujikawa Y, Sabokbar A, Neale SD, Itonaga I, Torisu T, Athanasou NA. The effect of macrophagecolony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factoralpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells. Bone. 2001; 28: 261-267. PMID: 11248655
38. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med. 1999; 190: 293-298. PMID: 10432291
39. Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T, et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood. 2001; 97: 785-791. PMID: 11157498
40. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994; 152: 4149-4156. PMID: 7511670
41. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature medicine. 2003; 9: 669-676. PMID: 12778165
42. Cho CS, Cho ML, Min SY, Kim WU, Min DJ, Lee SS, et al. CD40 engagement on synovial fibroblast upregulates production of vascular endothelial growth factor. J Immunol. 2000; 164: 5055-5061. PMID: 10799861
43. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factorkappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes. 1999; 48: 1131-1137. PMID: 10331420
44. Lee TH, Avraham H, Lee SH, Avraham S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. The Journal of biological chemistry. 2002; 277: 10445-10451. PMID: 11784713
45. Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, et al. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption. Arthritis and rheumatism. 2008; 58: 2397-2408. doi: 10.1002/art.23653 PMID: 18668542
46. Gronthos S, Zannettino AC. The role of the chemokine CXCL12 in osteoclastogenesis. Trends in endocrinology and metabolism: TEM. 2007; 18: 108-113. PMID: 17320408
47. Kim HR, Kim KW, Kim BM, Jung HG, Cho ML, Lee SH. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis & rheumatology. 2014; 66(3): 538-548.
48. Ikeda M, Hosoda Y, Hirose S, Okada Y, Ikeda E. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. The Journal of pathology. 2000; 191: 426-433. PMID: 10918218
49. Zhou JL, Liu SQ, Qiu B, Hu QJ, Ming JH, Peng H. Effects of hyaluronan on vascular endothelial growth factor and receptor-2 expression in a rabbit osteoarthritis model. J Orthop Sci. 2009; 14:313-9. doi: 10. 1007/s00776-009-1329-8 PMID: 19499299
50. Garcia-Gomez A, Ocio EM, Pandiella A, San Miguel JF, Garayoa M. RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications. Investigational new drugs. 2013; 31: 200-205. doi: 10.1007/s10637-012-9845-3 PMID: 22773056